This serves as an example of how seriously we must take the safety of the pharmaceutical supply chain.
Editor's note · Context
Burgess stresses the need for vigilance in pharmaceutical safety.
Share
More from Michael Burgess
May I inquire as to how much time is remaining. The SPEAKER pro tempore. The gentleman from Texas has 12\1/2\ minutes remaining.
I thank the gentlewoman for yielding. Mr. Speaker, the reason we are here is because the average family of four is paying over $17,000 more per year thanks to the policies of the Biden-Harris administration and their allies in Congress. In…
I am prepared to close after the gentleman closes. Mr. McGOVERN. Madam Speaker, may I inquire as to the time remaining. The SPEAKER pro tempore. The gentleman has 8\1/2\ minutes remaining. Mr. McGOVERN. Madam Speaker, I yield myself the…
I thank the gentleman from Georgia for yielding. I rise today to speak in support of the rule and the underlying bills: H.R. 8771, the Department of State, Foreign Operations, and Related Programs Appropriations Act; H.R. 8752, the…





